Knock Cancer Out of the Park!
Join us for a free evening of Fun and Fireworks as the Orioles' AA Minor League Bowie Baysox Knock Cancer Out of the Park! ECAN thanks [...]
A Message from our Founder
This week marks 15 years since my sweet husband Monte took his last breath on earth. Still filled with gratitude [...]
Campaign for Esophageal Cancer Research Funding
Over the past two years, more than $11 million in new federal funding has been awarded to Esophageal Cancer researchers [...]
Groundbreaking Study on How Barrett’s Esophagus becomes Cancer
A new study from Great Britain underscores the importance of early detection of Barrett's Esophagus in the fight to stop [...]
She Dealt with the Anguish of Losing Her Dad to Esophageal Cancer …
And went on to win the Silver Medal in the Tokyo Olympics in the Women's 1500 Meter competition! Erica Sullivan [...]
Small but Mighty, ECAN turns 12
Twelve years ago, a small but mighty group of dedicated folks who wanted to see significant change for patients [...]
Three New Immunotherapy Indications for Esophageal Cancer Patients
Since March 2021, the U.S. Food and Drug Administration has issued four approvals for PD-L1 Inhibitors for patients with Esophageal [...]
ECAN Experts cited in US News & World Report
"Esophageal Cancer: What to Know" is a new report from U.S. News & World Report by contributing writer David Levine. [...]
FDA Fast-Tracks Review of 3 New Immunotherapy Options for Esophageal Cancer Patients
The U.S. Food & Drug Administration has granted Priority Review for the use of immunotherapies in three new designations for [...]
New Treatment Option for Patients with HER2+ Gastroesophageal Junction Adenocarcinoma
The U.S. Food & Drug Administration has approved a new therapy for adult patients with locally advanced or metastatic HER2+ [...]